<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7073089/results/search/drug/results.xml">
  <result pre="polymerase, such as ganciclovir, valganciclovir, cidofovir, and foscarnet. At present," exact="ganciclovir" post="remains to be the first line drug for the"/>
  <result pre="the first line drug for the treatment of CMV infections." exact="Ganciclovir" post="and valganciclovir are mainly used for both preemptive therapy"/>
  <result pre="line drug for the treatment of CMV infections. Ganciclovir and" exact="valganciclovir" post="are mainly used for both preemptive therapy and prophylaxis"/>
  <result pre="to be used for prophylaxis after stem cell transplant [56]." exact="Cidofovir" post="is employed almost exclusively to treat CMV retinitis in"/>
  <result pre="[62]. However, it is not recommended to co-administer maribavir and" exact="ganciclovir" post="because maribavir is an inhibitor of the UL97 enzyme"/>
  <result pre="is commonly used when patients present with drug resistance (e.g.," exact="ganciclovir" post="and valganciclovir) [62,69]. Additionally, it is likely to be"/>
  <result pre="compounds because of its reduced haematotoxicity and nephrotoxicity, compared with" exact="ganciclovir" post="and valganciclovir [62]. Maribavir has been used to treat"/>
  <result pre="of its reduced haematotoxicity and nephrotoxicity, compared with ganciclovir and" exact="valganciclovir" post="[62]. Maribavir has been used to treat hematopoietic cell"/>
  <result pre="Brincidofovir Brincidofovir (CMX001) is an orally bioavailable lipid prodrug of" exact="cidofovir" post="which is less renal toxic than the parent compound."/>
  <result pre="is poor despite surgical resection, high-dose radiation, and chemotherapy with" exact="temozolomide" post="[88,89]. Activation of the immune system against tumor cells"/>
  <result pre="tissues. Batich et al. evaluated pp65-specific cellular responses following dose-intensified" exact="temozolomide" post="(DI-TMZ) with pp65- DCs and determined the effects on"/>
  <result pre="[94]. Following tumor resection, the patient received radiation therapy and" exact="temozolomide" post="combined therapy that was complicated by CMV colitis and"/>
  <result pre="foscarnet therapy remodels thymidine analogue mutations and alters resistance to" exact="zidovudine" post="and lamivudine in HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy"/>
  <result pre="remodels thymidine analogue mutations and alters resistance to zidovudine and" exact="lamivudine" post="in HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy plus concomitant"/>
  <result pre="HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy plus concomitant and adjuvant" exact="temozolomide" post="for glioblastomaN. Engl. J. Med.200535298799610.1056/NEJMoa04333015758009 61.OrnaghiS.HsiehL.S.BordeyA.VerganiP.PaidasM.J.van den PolA.N.Valnoctamide Inhibits"/>
  <result pre="randomized, dose-ranging, double-blind, phase 2 StudyClin. Infect. Dis.2019681255126410.1093/cid/ciy70630329038 71.HakkiM.Moving Past" exact="Ganciclovir" post="and Foscarnet: Advances in CMV TherapyCurr. Hematol. Malig. Rep.202010.1007/s11899-020-00557-6"/>
 </snippets>
</snippetsTree>
